How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Is your organisation fully prepared to structure MDR Technical Documentation under Annex II and Annex III?
REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

This guide translates the legal language of Annex II and Annex III into a practical, reviewer friendly structure that supports faster assessment by Notified Bodies. It explains how to present device information, design and manufacturing evidence, GSPR demonstrations, verification and validation data, clinical evaluation and PMS outputs in a coherent and logically connected way.
 
The document emphasises the MDR requirement for Technical Documentation to be clear, organised, readily searchable and unambiguous. It also highlights the most frequent causes of review delays including incomplete submissions, inconsistent terminology and dossiers that require reviewers to search for links between claims and evidence.
Through best practice recommendations and explanations of common Notified Body observations, the white paper guides manufacturers to create documentation that supports lifecycle consistency and reduces question cycles.

What’s changing?

Organisations must adapt to MDR review patterns in which Notified Bodies do not read dossiers linearly. Instead, they move quickly between intended purpose, classification, GSPR mapping, risk management, verification and validation, clinical evidence and PMS. To meet expectations, manufacturers need Technical Documentation that demonstrates:

  • Clean device definition including intended purpose, variants, accessories and Basic UDI DI scope
  • Complete and cohesive information supplied with the device including labels, IFU and promotional materials
  • Clear design and manufacturing information with traceable links between design inputs, outputs, risk controls and verification evidence
  • Robust GSPR mapping with precise evidence references and justification for applicability or non applicability
  • Risk management aligned with ISO 14971 and integrated with verification, validation, clinical evaluation, usability and PMS
  • Verification and validation evidence that is complete, traceable and supported by accredited laboratories
  • PMS systems that operate as lifecycle feedback mechanisms and drive updates to risk, clinical evidence and documentation
  • SSCP requirements for implantable and class III devices where transparency and alignment with clinical and PMS outputs are essential
These elements reflect Notified Body expectations for documentation that is consistent, traceable and supported by justifiable regulatory reasoning.

Why it matters for your business

Well structured MDR Technical Documentation directly influences review timelines, inspection performance and market access. Poor organisation or inconsistent evidence presentation typically leads to additional reviewer rounds and delayed CE marking.
 
Manufacturers must therefore:
  • Map all device information and evidence to a coherent MDR aligned structure
  • Maintain terminology consistency across all documents including CER, RMF, IFU and PMS
  • Demonstrate clear requirement to evidence traceability with updated GSPR matrices and verification and validation summaries
  • Strengthen design and risk management integration through complete traceability between user needs, design inputs, hazards, risk controls and testing
  • Ensure PMS outputs genuinely inform lifecycle safety and performance decisions and align with clinical and risk files
A mature dossier signals system control, regulatory readiness and a high degree of organisational quality. It supports operational efficiency and positions the business for smoother regulatory pathways.

Take action now

With the MDR in full effect and Notified Bodies operating under heavy demand, documentation quality has never been more important. Organisations that invest early in structuring, updating and maintaining their Technical Documentation will minimise delays, reduce review friction and build a more resilient compliance framework.
 
This white paper provides practical recommendations, traceability models, architecture templates and insights into common review pitfalls, helping manufacturers create a sustainable documentation system that remains compliant throughout the device lifecycle.
 

👉 Download the full white paper below to discover how to structure MDR Technical Documentation in a clear, reliable and reviewer ready way.

Download the White Paper below

 

MockUp Resource Hub Web

View our other resources and company news

ICH E6 Guide Header Image (1500 x 844 px) Case Study

From Cosmetics to OTC: Full FDA GMP Compliance Achieved in 12 Months

A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full ...
Read More
csv blog header jan 25 Article

GDP Transport Validation: A Practical Guide for Pharmaceutical Companies

Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide ...
Read More
QMS IMP Header image case study May 25 Article

Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide

The EU veterinary sector enters a new era on 16 July 2026. Dedicated GMP regulations replace EudraLex Volume 4 for veterinary products. Learn what changes ...
Read More
mock inspection blog header Case Study

Full GMP Internal Audit Program Executed On Time

A pharmaceutical manufacturer needed to complete their annual EU GMP internal audit cycle across 11 departments, without the internal capacity to do it. See how ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan QMS

From local to global: scaling your QMS for UK–EU operations

Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan QMS

Scale Your Quality System from UK to EU Without Losing Control

Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
SAP PALEX CSV Case Study Header Image (1500 x 844 px) Article

Pharmaceutical Equipment Qualification & Control System Validation

Qualifying process equipment and control systems is fundamental to GMP compliance. This guide breaks down how to define user requirements, apply risk-based testing, and maintain ...
Read More
mock inspection blog header Case Study

GMP Consultancy for a New Cannabis Manufacturing Plant

A start up cannabis manufacturer partnered with Rephine to design a GMP compliant facility, implement a practical Quality Management System and prepare for EU GMP ...
Read More
QMS IMP Header image case study May 25 Article

How an Internal Services Audit Can Maximise Your Regulatory Compliance

Internal services audits play a critical role in maintaining GMP compliance and driving continuous improvement. This article explores how structured gap assessments, internal audits and ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards